TABLE OF CONTENTS
Detailed Table of Contents
Chapter 1 — Executive Summary
1.1Market Overview
1.22025 Market Size and 2035 Forecast
1.3Largest and Fastest-Growing Segments
1.4Key Country and Regional Highlights
1.5Competitive Positioning
1.6Strategic Recommendations
Chapter 2 — Research Scope and Methodology
2.1Market Definitions and Boundaries
2.2Base Year and Forecast Period
2.3Primary Research
2.4Secondary Research
2.5Bottom-Up Market Estimation
2.6Top-Down Market Estimation
2.7Data Triangulation
2.8Forecast Assumptions and Limitations
Chapter 3 — Market Dynamics
3.1Growth Drivers
3.2Market Restraints
3.3Growth Opportunities
3.4Industry Challenges
3.5Emerging Trends
3.6Porter’s Five Forces
3.7Value Chain and Pricing Analysis
Chapter 4 — Technology, Regulatory and Commercial Landscape
4.1Technology Evolution
4.2Product Innovation and Pipeline
4.3Regulatory Approvals and Compliance
4.4Clinical and Performance Evidence
4.5Reimbursement and Payer Access
4.6Distribution and Procurement
4.7Digital Integration and Interoperability
Chapter 5 — Market Size and Forecast, 2025–2035
5.1Market Revenue, 2025–2035
5.2Year-on-Year Growth and CAGR
5.3Revenue by Segment
5.4Largest Segment and Growth Rationale
5.5Fastest-Growing Segment and Growth Rationale
5.6Forecast Scenarios and Sensitivities
Chapter 6 — Market Analysis, by Device Type
6.1Overview and Market Definition
6.2Revenue and Forecast, 2025–2035
6.3Subsegment Analysis
6.3.1Insulin Pens: Disposable and Reusable
6.3.2Pen Needles
6.3.3Insulin Syringes
6.3.4Insulin Pumps: Tethered and Patch
6.3.5Other Delivery Devices
6.4Largest Subsegment: Share and Drivers
6.5Fastest-Growing Subsegment: CAGR and Drivers
6.6Competitive and Commercial Implications
Chapter 7 — Market Analysis, by Therapy
7.1Overview and Market Definition
7.2Revenue and Forecast, 2025–2035
7.3Subsegment Analysis
7.3.1Multiple Daily Injections
7.3.2Continuous Subcutaneous Insulin Infusion
7.3.3Automated Insulin Delivery
7.4Largest Subsegment: Share and Drivers
7.5Fastest-Growing Subsegment: CAGR and Drivers
7.6Competitive and Commercial Implications
Chapter 8 — Market Analysis, by End User
8.1Overview and Market Definition
8.2Revenue and Forecast, 2025–2035
8.3Subsegment Analysis
8.3.1Homecare
8.3.2Hospitals
8.3.3Specialty Clinics
8.4Largest Subsegment: Share and Drivers
8.5Fastest-Growing Subsegment: CAGR and Drivers
8.6Competitive and Commercial Implications
Chapter 9 — Market Analysis, by Distribution Channel
9.1Overview and Market Definition
9.2Revenue and Forecast, 2025–2035
9.3Subsegment Analysis
9.3.1Retail
9.3.2Hospital
9.3.3Online
9.4Largest Subsegment: Share and Drivers
9.5Fastest-Growing Subsegment: CAGR and Drivers
9.6Competitive and Commercial Implications
Chapter 10 — Regional and Country Market Analysis
10.1Regional Market Share and Forecast, 2025–2035
10.2North America
10.2.1United States
10.2.2Canada
10.2.3Mexico
10.3Europe
10.3.1Germany
10.3.2United Kingdom
10.3.3France
10.3.4Italy
10.3.5Spain
10.3.6Netherlands
10.3.7Switzerland
10.3.8Nordic Countries
10.3.9Rest of Europe
10.4Asia Pacific
10.4.1China
10.4.2Japan
10.4.3India
10.4.4South Korea
10.4.5Australia
10.4.6Southeast Asia
10.4.7Rest of Asia Pacific
10.5Latin America
10.5.1Brazil
10.5.2Argentina
10.5.3Chile
10.5.4Colombia
10.5.5Rest of Latin America
10.6Middle East & Africa
10.6.1Saudi Arabia
10.6.2United Arab Emirates
10.6.3South Africa
10.6.4Turkey
10.6.5Rest of Middle East & Africa
10.7Largest Geography and Underlying Drivers
10.8Fastest-Growing Geography and Underlying Drivers
Chapter 11 — Competitive Landscape
11.1Competitive Structure
11.2Market Share and Concentration
11.3Product and Technology Benchmarking
11.4Pricing and Distribution Benchmarking
11.5Mergers and Acquisitions
11.6Partnerships and Collaborations
11.7New Product Launches
11.8Geographic Expansion
Chapter 12 — Company Profiles
12.1Medtronic
12.1.1Company Overview
12.1.2Relevant Product and Service Portfolio
12.1.3Financial Performance (Where Disclosed)
12.1.4Geographic Presence
12.1.5Recent Strategic Developments
12.1.6SWOT and Competitive Positioning
12.2Insulet
12.2.1Company Overview
12.2.2Relevant Product and Service Portfolio
12.2.3Financial Performance (Where Disclosed)
12.2.4Geographic Presence
12.2.5Recent Strategic Developments
12.2.6SWOT and Competitive Positioning
12.3Tandem Diabetes Care
12.3.1Company Overview
12.3.2Relevant Product and Service Portfolio
12.3.3Financial Performance (Where Disclosed)
12.3.4Geographic Presence
12.3.5Recent Strategic Developments
12.3.6SWOT and Competitive Positioning
12.4Ypsomed
12.4.1Company Overview
12.4.2Relevant Product and Service Portfolio
12.4.3Financial Performance (Where Disclosed)
12.4.4Geographic Presence
12.4.5Recent Strategic Developments
12.4.6SWOT and Competitive Positioning
12.5Novo Nordisk
12.5.1Company Overview
12.5.2Relevant Product and Service Portfolio
12.5.3Financial Performance (Where Disclosed)
12.5.4Geographic Presence
12.5.5Recent Strategic Developments
12.5.6SWOT and Competitive Positioning
12.6Eli Lilly
12.6.1Company Overview
12.6.2Relevant Product and Service Portfolio
12.6.3Financial Performance (Where Disclosed)
12.6.4Geographic Presence
12.6.5Recent Strategic Developments
12.6.6SWOT and Competitive Positioning
12.7Sanofi
12.7.1Company Overview
12.7.2Relevant Product and Service Portfolio
12.7.3Financial Performance (Where Disclosed)
12.7.4Geographic Presence
12.7.5Recent Strategic Developments
12.7.6SWOT and Competitive Positioning
12.8Embecta
12.8.1Company Overview
12.8.2Relevant Product and Service Portfolio
12.8.3Financial Performance (Where Disclosed)
12.8.4Geographic Presence
12.8.5Recent Strategic Developments
12.8.6SWOT and Competitive Positioning
12.9Owen Mumford
12.9.1Company Overview
12.9.2Relevant Product and Service Portfolio
12.9.3Financial Performance (Where Disclosed)
12.9.4Geographic Presence
12.9.5Recent Strategic Developments
12.9.6SWOT and Competitive Positioning
12.10SOOIL Development
12.10.1Company Overview
12.10.2Relevant Product and Service Portfolio
12.10.3Financial Performance (Where Disclosed)
12.10.4Geographic Presence
12.10.5Recent Strategic Developments
12.10.6SWOT and Competitive Positioning
Chapter 13 — Appendix
13.1Market Definitions and Acronyms
13.2Currency and Exchange Rate Assumptions
13.3Forecast Modeling Notes
13.4Source and Data Limitations
13.5Research Disclaimer